QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series.

被引：0
|
作者：
Gavai, AV [1 ]
Vaz, RJ [1 ]
Santone, K [1 ]
Chandrasena, G [1 ]
Nayeem, A [1 ]
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 226卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
354-MEDI
引用
收藏
页码：U66 / U66
页数：1
相关论文
共 50 条
  • [41] Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol
    Bramer, SL
    Suri, A
    CLINICAL PHARMACOKINETICS, 1999, 37 (Suppl 2) : 41 - 51
  • [42] Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics
    Belle, DJ
    Ernest, CS
    Sauer, JM
    Smith, BR
    Thomasson, HR
    Witcher, JW
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11): : 1219 - 1227
  • [43] Mechanism-based inhibition of CYP2D6 by paroxetine.
    Bertelsen, KM
    Venkatakrishnan, K
    von Moltke, LL
    Obach, RS
    Greenblatt, DJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P77 - P77
  • [44] Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition
    Deodhar, Malavika
    Al Rihani, Sweilem B.
    Darakjian, Lucy
    Turgeon, Jacques
    Michaud, Veronique
    PHARMACEUTICS, 2021, 13 (02) : 1 - 10
  • [45] Inhibition of CYP2D6 by Quinidine and its Effects on the Metabolism of Cilostazol
    Steven L. Bramer
    Ajit Suri
    Clinical Pharmacokinetics, 1999, 37 : 41 - 51
  • [46] Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
    Charoenchokthavee, Wanaporn
    Panomvana, Duangchit
    Sriuranpong, Virote
    Areepium, Nutthada
    BREAST CANCER-TARGETS AND THERAPY, 2016, 8 : 149 - 155
  • [47] QSAR Studies of CYP2D6 Inhibitor Aryloxypropanolamines Using 2D and 3D Descriptors
    Roy, Partha Pratim
    Roy, Kunal
    CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 73 (04) : 442 - 455
  • [48] Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol
    Shin, JG
    Kane, K
    Flockhart, DA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (01) : 45 - 52
  • [49] Induction of CYP2D6 in pregnancy
    Wadelius, M
    Darj, E
    Frenne, G
    Rane, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (04) : 400 - 407
  • [50] A MOUSE MODEL FOR INVESTIGATING HUMAN BRAIN CYP2D6
    Tolledo, Edgor Cole
    Stocco, Marlaina
    Miksys, Sharon
    Gonzales, Frank
    Wadji, Fariba B.
    Zhao, Bin
    Tyndale, Rachel F.
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S15 - S15
12345